Lymphoma
Showing NaN - NaN of 77
Leukemia, Lymphoma Trial in United States (SCRI-CAR22v2)
Recruiting
- Leukemia
- Lymphoma
- SCRI-CAR22v2
-
Los Angeles, California
- +4 more
Jan 18, 2023
Ovarian Reserve in Younger Newly Diagnosed Lymphomas
Active, not recruiting
- Anaplastic Large Cell Lymphoma
- +4 more
- Laboratory Biomarker Analysis
- Questionnaire Administration
-
Birmingham, Alabama
- +106 more
Jan 11, 2023
Lymphoma Trial in United States (biological, drug, radiation)
Active, not recruiting
- Lymphoma
- rituximab
- +5 more
-
Anchorage, Alaska
- +258 more
Sep 23, 2022
Advanced Malignant Solid Tumor, Bladder Carcinoma, Breast Carcinoma Trial in Guam, Puerto Rico, United States (drug, procedure,
Recruiting
- Advanced Malignant Solid Neoplasm
- +49 more
- Adavosertib
- +36 more
-
Birmingham, Alabama
- +1429 more
Aug 17, 2022
Lymphoma, Nonneoplastic Condition Trial in United States (bleomycin sulfate, filgrastim, ABVD regimen)
Completed
- Lymphoma
- Nonneoplastic Condition
- bleomycin sulfate
- +11 more
-
Tucson, Arizona
- +422 more
Aug 16, 2022
Collecting and Storing Tissue From Young Patients With Cancer
Recruiting
- Acute Lymphoblastic Leukemia
- +13 more
- Cytology Specimen Collection Procedure
- Laboratory Biomarker Analysis
-
Birmingham, Alabama
- +68 more
Aug 4, 2022
Hematopoietic and Lymphoid System Tumor, Leukemia, Lymphoma Trial in Canada, United States (procedure, biological, other)
Active, not recruiting
- Hematopoietic and Lymphoid System Neoplasm
- +3 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +3 more
-
Birmingham, Alabama
- +42 more
Jul 20, 2022
Leukemia, Lymphoma Trial in Canada, United States (Patient-derived CD19- and CD22 specific CAR)
Recruiting
- Leukemia
- Lymphoma
- Patient-derived CD19- and CD22 specific CAR
-
Los Angeles, California
- +4 more
Apr 2, 2022
Breast Cancer, Lymphoma Trial in United States (Atorvastatin, Placebo)
Multiple Myeloma, Lymphoma Trial in Washington, Hackensack (Ipilimumab, Nivolumab)
Active, not recruiting
- Multiple Myeloma
- Lymphoma
-
Washington, District of Columbia
- +1 more
Dec 2, 2021
Lymphoma Trial in Washington, Baltimore (rituximab, sargramostim, EPOCH regimen)
Withdrawn
- Lymphoma
- rituximab
- +7 more
-
Washington, District of Columbia
- +1 more
Oct 19, 2021
Lymphoma Trial in Canada, United States (rituximab)
Completed
- Lymphoma
- rituximab
-
Duarte, California
- +7 more
Jul 30, 2020
Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in United States (biological, drug, procedure, radiation)
Withdrawn
- Leukemia
- +4 more
- alemtuzumab
- +6 more
-
La Jolla, California
- +23 more
Nov 25, 2019
DLBCL, Lymphoma, Diffuse Large-Cell, Diffuse Large-Cell Lymphoma Trial in United States (Bendamustine, Rituximab)
Completed
- Diffuse Large B-Cell Lymphoma
- +3 more
-
Boone, North Carolina
- +6 more
Apr 28, 2017
Lymphoma Trial in United States (doxorubicin HCl, vinblastine, standard subtotal nodal irradiation)
Completed
- Lymphoma
- doxorubicin hydrochloride
- +2 more
-
La Jolla, California
- +21 more
Feb 16, 2017
Solid Tumors, Lymphoma, Multiple Myeloma Trial in Washington (CS-7017 and Bexarotene)
Terminated
- Solid Tumors
- +2 more
- CS-7017 and Bexarotene
-
Washington, District of ColumbiaGeorgetown Lombardi Comprehensive Cancer Center
Feb 13, 2017
Cachexia, Lymphoma, Lymphoproliferative Disorder Trial in Canada, United States (Juven, Non-Juven Supplement)
Completed
- Cachexia
- +3 more
- Juven
- Non-Juven Supplement
-
Birmingham, Alabama
- +249 more
Dec 6, 2016
Lymphoma, Infection, Leukemia Trial in United States (Fluconazole, Voriconazole)
Completed
- Lymphoma
- +2 more
-
Birmingham, Alabama
- +32 more
Aug 1, 2016
Leukemia, Lymphoma Trial in United States (filgrastim, rituximab, cyclophosphamide)
Completed
- Leukemia
- Lymphoma
- filgrastim
- +12 more
-
San Diego, California
- +30 more
Jul 1, 2016